Eton Pharmaceuticals, Inc. (ETON) Balance Sheet
As of 2026-06-30 (10-Q), Eton Pharmaceuticals, Inc. (ETON) reported total assets of $115.8M, total liabilities of $69.2M and shareholders' equity of $46.6M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $26.8M. Long-term debt: $19.1M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ETONEton Pharmaceuticals, Inc.Follow ETON — free
—
Price chart with a free account
- Market cap
- 1.4B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 26.7 | 12.1 | 21.3 | 14.4 | 16.3 | 21.4 | 14.9 | 25.9 | 26.8 | |
| Receivables | — | 0.5 | 0.0 | 5.5 | 1.9 | 3.4 | 5.4 | 11.8 | 24.9 | |
| Inventory | — | 0.4 | 1.2 | 0.6 | 0.6 | 0.9 | 15.2 | 15.4 | 10.1 | |
| Current assets | 27.5 | 15.0 | 24.7 | 23.6 | 20.0 | 26.8 | 41.0 | 60.6 | 68.6 | |
| Total assets | 28.3 | 17.1 | 26.3 | 27.5 | 25.0 | 31.7 | 76.1 | 92.1 | 115.8 | |
| Current liabilities | 2.0 | 2.0 | 3.8 | 4.6 | 6.5 | 16.2 | 19.9 | 38.5 | 45.1 | |
| Long-term debt | — | 4.5 | 6.5 | 5.3 | 5.4 | 0.0 | 29.8 | 21.8 | 19.1 | |
| Short-term debt | — | — | — | 1.4 | 1.0 | 5.4 | 0.0 | 8.8 | 8.8 | |
| Total liabilities | 2.0 | 6.5 | 10.7 | 9.8 | 12.0 | 16.3 | 51.7 | 66.0 | 69.2 | |
| Shareholders' equity | 26.3 | 10.6 | 17.6 | 17.6 | 13.1 | 15.5 | 24.4 | 26.2 | 46.6 |
USD millions · SEC XBRL
Eton Pharmaceuticals, Inc. — questions
- How much cash does Eton Pharmaceuticals, Inc. have?
- $26.8M in cash and cash equivalents as of 2026-06-30.
- How much debt does Eton Pharmaceuticals, Inc. have?
- $19.1M of long-term debt and $8.8M due within a year as of 2026-06-30.
- What are Eton Pharmaceuticals, Inc.'s total assets?
- $115.8M as of 2026-06-30.
- What is Eton Pharmaceuticals, Inc.'s shareholders' equity?
- $46.6M as of 2026-06-30.
Every figure on this page comes from Eton Pharmaceuticals, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.